Aoki, Ryousuke
Matsuzaki, Keiichi
Suzuki, Hitoshi https://orcid.org/0000-0002-1901-2111
Kagimura, Tatsuo
Sofue, Tadashi
Wada, Takashi
Narita, Ichiei
Suzuki, Yusuke
Article History
Received: 31 March 2025
Accepted: 20 April 2026
First Online: 18 May 2026
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The BRIGHTEN study was funded by Kyowa Kirin Co. Ltd. (KKC). KKC proposed the concept of this trial and provided information, but did not take any part in collecting, analysing, or interpreting the results. The Translational Research Centre for Medical Innovation, a third-party organization that is independent of the primary investigator’s institution, was contracted to perform the trial and manage the data. TW received honoraria, subsidies, and donations from Kyowa Kirin. TS received a grant from Kyowa Kirin, Japan. IN received lecture fees and grants from Kyowa Kirin (KK). Other authors declare no conflicts of interest.
: Approval for the study was granted by the Institutional Review Board of Niigata University (No. MH26-004), and Institutional Review Board of Juntendo University Hospital (No. C23-0036) in accordance with the Declaration of Helsinki. Informed consent was obtained from all participants involved in this study.